Sharp Therapeutics Corp. (TSXV:SHRX)
Canada · Delayed Price · Currency is CAD 2.150
0.00 (0.00%)
At close: Apr 2, 2026
Sharp Therapeutics Market Cap
Sharp Therapeutics has a market cap or net worth of CAD 64.66 million as of April 10, 2026.
Market Cap
64.66M
Enterprise Value
63.69M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.15
Market Cap Chart
Since January 17, 2025, Sharp Therapeutics's market cap has increased from 62.09M to 64.66M, an increase of 4.15%. That is a compound annual growth rate of 3.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 64.66M | -13.82% |
| Dec 30, 2025 | 75.03M | 20.85% |
| Jan 17, 2025 | 62.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ME Therapeutics Holdings | 75.12M |
| NurExone Biologic | 61.67M |
| Sernova Biotherapeutics | 57.84M |
| Medicenna Therapeutics | 54.22M |
| BriaCell Therapeutics | 44.30M |
| MedMira | 42.10M |
| Defence Therapeutics | 40.06M |
| Devonian Health Group | 33.37M |